Entera Bio ENTX reported its Q1 earnings results on Thursday, May 12, 2022 at 08:30 AM.
Here's what investors need to know about the announcement.
Earnings
Entera Bio beat estimated earnings by 27.78%, reporting an EPS of $-0.13 versus an estimate of $-0.18.
Revenue was down $89.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.44 which was followed by a 0.93% increase in the share price the next day.
Here's a look at Entera Bio's past performance:
Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
---|---|---|---|---|
EPS Estimate | -0.23 | -0.11 | -0.12 | -0.12 |
EPS Actual | 0.21 | -0.09 | -0.21 | -0.43 |
Revenue Estimate | 130.00K | 60.00K | 90.00K | 90.00K |
Revenue Actual | 165.00K | 140.00K | 109.00K | 157.00K |
To track all earnings releases for Entera Bio visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.